MedTrace Logo

Use of FDG PET/CT to Evaluate Crohn Disease

NCT00383344 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-12-09

No results posted yet for this study

Summary

The purpose of this study will permit to determine the role of FDG PET/CT to diagnose Crohn Disease and recurrence of Crohn disease after having compared results of PET/CT's with results of exams routinely performed(colonoscopy and bowel follow through).

Conditions

  • Crohn Disease

Interventions

PROCEDURE

FDG PET/CT

Sponsors & Collaborators

  • Eric Turcotte

    lead OTHER

Principal Investigators

  • François Bénard, MD · Université de Sherbrooke

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-01
Primary Completion
2007-05-01
Completion
2007-05-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00383344 on ClinicalTrials.gov